Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.170
-0.030 (-1.36%)
Mar 14, 2025, 10:55 AM EDT - Market open

Gain Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Gain Therapeutics stock have an average target of 8.33, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 283.87% from the current stock price of 2.17.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $8.33 $8.00 $12
Change +176.50% +283.87% +268.66% +453.00%

Analyst Ratings

The average analyst rating for Gain Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 223333
Buy 222223
Hold 000000
Sell 000000
Strong Sell 000000
Total 445556

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Scotiabank
Scotiabank
Buy
Initiates
$12
Buy Initiates $12 +453.00% Mar 7, 2025
Roth MKM
Roth MKM
Strong Buy
Maintains
$7
Strong Buy Maintains $7 +222.58% Dec 24, 2024
Roth MKM
Roth MKM
Strong Buy
Initiates
$7
Strong Buy Initiates $7 +222.58% Dec 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 +268.66% Nov 25, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 +268.66% Oct 9, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 55.18K
Revenue Next Year
51.00K
EPS This Year
-1.00
from -1.71
EPS Next Year
-0.83
from -1.00
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
--133.93K132.64K55.18K-51.00K-
Revenue Growth
----0.96%-58.40%---
EPS
-0.97-1.33-1.37-1.48-1.71-1.00-0.83-1.23
EPS Growth
--------
Forward PE
--------
No. Analysts -----874
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High n/a 210,000 n/a
Avg n/a 51,000 n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20242025202620272028
High -0.99 -0.60 -1.06
Avg -1.00 -0.83 -1.23
Low -1.06 -1.13 -1.38

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.